Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06417177 · ClinicalTrials.gov registry record · Early Phase 1
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
A Early Phase 1 study of Aging and Menopause, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT06417177: Recruiting Early Phase 1 study of Aging and Menopause, sponsored by University of Missouri-Columbia.
NCT06417177 is a Early Phase 1 study of Aging and Menopause that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 75 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06417177, a Early Phase 1 study of Aging and Menopause, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.
Primary Outcome
Blood flow in the forearm measured with venous occlusion plethysmography.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Propranolol
- DRUG Gemtesa
Study Locations (1)
Missouri
- University of Missouri-Columbia - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2026-07 |
| Phase | Early Phase 1 |
What NCT06417177 shows while recruiting
NCT06417177 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06417177 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06417177 about?
NCT06417177 is a clinical study titled "Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia". The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.
What is the current status of trial NCT06417177?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 75 participants. The study started on 2024-06-03. Estimated completion is 2026-07.
What conditions does trial NCT06417177 study?
This clinical trial studies the following conditions: Aging, Menopause, Hypoxia, Vasodilation.
What interventions are being tested in trial NCT06417177?
The interventions under investigation include: Placebo (DRUG), Propranolol (DRUG), Gemtesa (DRUG).
Who is sponsoring clinical trial NCT06417177?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06417177 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06417177's enrollment target sits among peer trials
75 115th of 262 higher than 146 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gene Expression Changes In Young and Geriatric Skin
RECRUITING · Early Phase 1
-
Examining the Effects of Theta Burst TMS on Brain Connectivity and Balance Ability in Older Adults With Balance Problems
RECRUITING · Early Phase 1
-
Transient Receptor Potential Channels
RECRUITING · Early Phase 1
-
Early Neurovascular Adaptations in Aging Women
RECRUITING · Early Phase 1
-
Heat, Microvascular Function and Aging
RECRUITING · Early Phase 1
-
Angiotensin-(1-7) Cardiovascular Effects in Aging
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI